---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-050854"
form_type: "8-K"
ticker: "NUS"
cik: "0001021561"
company_name: "NU SKIN ENTERPRISES, INC."
filed_at: "2023-11-01T23:59:59+00:00"
generated_at: "2026-06-09T01:48:33.313864+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Nu Skin Q3 revenue down 7% to $498.8M; GAAP EPS $(0.74); guides FY23 revenue $1.92-1.96B

## Summary
- Q3 revenue $498.8M vs $537.8M prior; GAAP EPS loss $(0.74) including $65.7M inventory write-off.
- Non-GAAP EPS $0.56; customers 978,907 (-21%), paid affiliates 186,162 (-23%).
- Q4 outlook revenue $440-480M, EPS $(0.14)-$0.01 or $0.15-$0.30 non-GAAP; full-year EPS $1.62-$1.77 non-GAAP.
- Restructuring program with $15-25M severance charges in Q4 2023, expected completion by H1 2024.
- EVP Connie Tang resigns effective Oct 31, 2023, remains advisor through April 2024; CEO overseeing her org.

## SEC filing metadata
- accession: 0001140361-23-050854
- form_type: 8-K
- ticker: NUS
- cik: 0001021561
- company_name: NU SKIN ENTERPRISES, INC.
- filed_at: 2023-11-01T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 2.05, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1021561/000114036123050854/0001140361-23-050854-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1021561/000114036123050854/ef20013810_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-050854
- JSON: https://secwatch.observer/filing/0001140361-23-050854.json
- Plain text: https://secwatch.observer/filing/0001140361-23-050854.txt

## Key facts
- Earnings Releases
  NU SKIN ENTERPRISES, INC. reported third quarter 2023 results: revenue $498.8 million, EPS $(0.74). Guidance reaffirmed.
  - Period: third quarter 2023
  - Revenue: $498.8 million
  - EPS: $(0.74)
  - Guidance: reaffirmed
  - Result: reported results
  source text: Results PROVO, Utah — Nov. 1, 2023 — Nu Skin Enterprises Inc. (NYSE: NUS) today announced third quarter 2023 results. Executive Summary Q3 2023 vs. Prior-year Quarter Revenue $498.8 million; (7)% • (1)% FX impact or $(8.1) million Earnings Per Share (EPS) $(0.74) or $0.56 excluding an inventory write-off compared to $(0.51) or $0.47 excluding restructuring and
  evidence_url: https://www.sec.gov/Archives/edgar/data/1021561/000114036123050854/0001140361-23-050854-index.htm
- Executive change
  Connie Tang resigned as Executive Vice President and Chief Global Growth and Customer Experience Officer at NU SKIN ENTERPRISES, INC..
  - Action: resigned
  - Role: Executive Vice President and Chief Global Growth and Customer Experience Officer
  source text: Connie Tang notified the Company that, due to family health reasons, she determined to resign from her position as Executive Vice President and Chief Global Growth and Customer Experience Officer, effective October 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1021561/000114036123050854/0001140361-23-050854-index.htm
- Restructurings & Charges
  NU SKIN ENTERPRISES, INC. announced a restructuring with charges of $15–$25 million in severance charges (workforce reductions).
  - Type: restructuring
  - Charge: $15–$25 million in severance charges
  - Headcount: workforce reductions
  source text: On October 27, 2023, the Company adopted a strategic plan to focus resources on the Company’s global priorities and optimize future growth and profitability (the “global program”). The global program includes workforce reductions. The Company estimates total charges for the fourth quarter of 2023 under the global program will approximate $15–$25 million in severance charges, which will be paid in cash.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1021561/000114036123050854/0001140361-23-050854-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.